The Therapeutic Effect of Nordic Walking on Freezing of Gait in Parkinson's Disease: A Pilot Study
Overview
Affiliations
Methods: Twenty PD subjects trained NW for 12 weeks, with a frequency of twice per week. Each session lasted about 60 minutes. Twenty patients in the control group did not use any form of physiotherapy (no-intervention group). Freezing of Gait Questionnaire (FOGQ), the Timed Up and Go (TUG) test, and the Provocative Test for Freezing and Motor Blocks (PTFMB) were performed at baseline, immediately after the end of NW program, and three months later.
Results: The results of FOGQ, TUG, and total PTFMB revealed significant improvement after completing the exercise program, and this effect persisted at follow-up. The results of the PTFMB subtests showed a different effect of NW on particular subtypes of FoG. Start hesitation, sudden transient blocks that interrupt gait, and blocks on turning improved considerably, while motor blocks, when walking through narrow space and on reaching the target, did not respond to NW training. . The results show, for the first time, that FoG during turning and step initiation, two most common forms of this gait disorder, has been significantly reduced by NW training. Different responses of particular subtypes of FoG to NW probably reflect their different pathophysiologies.
Conclusions: The present study showed that NW training had a beneficial effect on FOG in PD and that the achieved improvement is long-lasting. Future research should clarify whether the observed improvement limited to FoG triggered by only some circumstances reflects different pathomechanisms of FoG subtypes.
Ernst M, Folkerts A, Gollan R, Lieker E, Caro-Valenzuela J, Adams A Cochrane Database Syst Rev. 2024; 4:CD013856.
PMID: 38588457 PMC: 11001292. DOI: 10.1002/14651858.CD013856.pub3.
He S, Fang W, Wu J, Lv H, Zhang J, Wang T Front Psychol. 2023; 14:1162574.
PMID: 37780170 PMC: 10540073. DOI: 10.3389/fpsyg.2023.1162574.
Hayek M, Lobo Jofili Lopes J, LeLaurin J, Gregory M, Abi Nehme A, McCall-Junkin P JAMA Netw Open. 2023; 6(7):e2324860.
PMID: 37477916 PMC: 10362470. DOI: 10.1001/jamanetworkopen.2023.24860.
Ernst M, Folkerts A, Gollan R, Lieker E, Caro-Valenzuela J, Adams A Cochrane Database Syst Rev. 2023; 1:CD013856.
PMID: 36602886 DOI: 10.1002/14651858.CD013856.pub2.
Yang C, Huang J, Wang T, Tan Y, Chen Y, Zhao Z BMC Neurol. 2022; 22(1):505.
PMID: 36581847 PMC: 9797903. DOI: 10.1186/s12883-022-03027-z.